Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, ...

These days, one doesn’t experience the news on these platforms before seeing the memes and reactions—the reaction and the ...

Nostalgia has become one of the most powerful currencies in Bollywood’s contemporary marketing apparatus. The recycling of ...

Introduction Application of artificial intelligence (AI) tools in the healthcare setting gains importance especially in the domain of disease diagnosis. Numerous studies have tried to explore AI in ...

This article, presented in the backdrop of the debates on the state of political theory in India, argues that the terms of debate need to shift to include the question of method of doing political ...

Between Choice and Fate at Batsford Gallery has a very charged yet subtle quality. The gallery’s atmosphere seems more akin ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Peter Krull, director of Earth Equity Advisors, discusses why he's bullish on renewable energy and shares his top clean ...

Former Google CEO Eric Schmidt declared his own programming expertise obsolete after watching an AI system autonomously ...